Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1452
-
Total 13F shares, excl. options
-
1,013,158,831
-
Shares change
-
-2,971,715
-
Total reported value, excl. options
-
$64,205,170,698
-
Value change
-
-$201,708,522
-
Put/Call ratio
-
1.47%
-
Number of buys
-
658
-
Number of sells
-
-690
-
Price
-
$63.38
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2019
1,610 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2019.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,452 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,013,158,831 shares
of 1,240,722,841 outstanding shares and own 81.66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (102,486,335 shares), BlackRock Inc. (100,004,286 shares), Capital Research Global Investors (76,789,022 shares), STATE STREET CORP (57,382,100 shares), Bank of New York Mellon Corp (28,197,040 shares), Invesco Ltd. (22,999,911 shares), Capital World Investors (21,228,494 shares), GEODE CAPITAL MANAGEMENT, LLC (18,688,224 shares), Dodge & Cox (17,436,521 shares), and NORTHERN TRUST CORP (17,129,707 shares).
This table shows the top 1452 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.